Plan du site
[pagelist exclude= »349,367″]
Nouvelles
It’s time for action, it’s World Hepatitis Day 2024!
Every year, 1.3 million people lose their lives to hepatitis. New data from the World Health Organization shows the number of deaths is rising. The TherVacB team is not waiting for change. Together with researchers from the D-Solve consortium and supporting partners,...
Researchers from “IP-cure-B” & “TherVacB” continue the dialogue to advance elimination of chronic hepatitis B
Researchers from the two EC-funded projects ‘IP-cure-B – Take care of your health’ and ‘TherVacB - A therapeutic vaccine to cure Hepatitis B’ continue their collaboration to jointly tackle some of the major challenges in the therapy of viral hepatitis.Building on a...
Bavarian Award ‘m4’ honours the TherVacB innovative therapeutic vaccine as a promising solution to the global health challenge of chronic hepatitis B
Professor Ulrike Protzer and her TherVacB team at Helmholtz Munich and TUM have been honoured with the prestigious Bavarian m4 Award 2023. Key members of the Helmholtz Munich and TUM team for TherVacB proudly received the m4 Award on 24 October 2023 at Munich...